Your browser doesn't support javascript.
loading
Wnt/ß­catenin signaling is a novel therapeutic target for tumor suppressor CYLD­silenced glioblastoma cells.
Kanemaru, Ayumi; Ito, Yuki; Yamaoka, Michiko; Shirakawa, Yuki; Yonemaru, Kou; Miyake, Shunsuke; Ando, Misaki; Ota, Masako; Masuda, Takeshi; Mukasa, Akitake; Li, Jian-Dong; Saito, Hideyuki; Hide, Takuichiro; Jono, Hirofumi.
Affiliation
  • Kanemaru A; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
  • Ito Y; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
  • Yamaoka M; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
  • Shirakawa Y; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo 113­8421, Japan.
  • Yonemaru K; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
  • Miyake S; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
  • Ando M; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
  • Ota M; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
  • Masuda T; Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 862­0973, Japan.
  • Mukasa A; Department of Neurosurgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
  • Li JD; Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
  • Saito H; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
  • Hide T; Department of Neurosurgery, Kitasato University School of Medicine, Sagamihara, Kanagawa 252­0375, Japan.
  • Jono H; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860­8556, Japan.
Oncol Rep ; 50(5)2023 Nov.
Article in En | MEDLINE | ID: mdl-37772388
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Japan Country of publication: Greece
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Japan Country of publication: Greece